Ceryvyn Therapeutics Limited CYVNY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -57.16% | -55.32% | -83.23% | -83.37% | -71.89% |
| Total Receivables | -90.02% | -89.59% | -94.73% | -94.77% | -35.62% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -25.08% | -21.86% | -72.51% | -72.74% | -80.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -61.14% | -59.47% | -83.55% | -83.69% | -69.80% |
|
|
|||||
| Total Current Assets | -61.14% | -59.47% | -83.55% | -83.69% | -69.80% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -61.14% | -59.47% | -83.74% | -83.87% | -69.89% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | 7.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 265,676.77% |
| Total Finance Division Other Current Liabilities | -83.55% | -82.84% | -98.16% | -98.17% | -84.51% |
| Total Other Current Liabilities | -83.55% | -82.84% | -98.16% | -98.17% | -84.51% |
| Total Current Liabilities | -99.38% | -99.35% | -98.68% | -98.69% | 302.87% |
|
|
|||||
| Total Current Liabilities | -99.38% | -99.35% | -98.68% | -98.69% | 302.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -99.38% | -99.35% | -99.61% | -99.62% | -2.47% |
|
|
|||||
| Common Stock & APIC | 6.17% | 10.72% | -1.79% | -2.61% | 2.40% |
| Retained Earnings | 26.47% | 23.32% | 29.50% | 30.09% | -23.28% |
| Treasury Stock & Other | 8.60% | 13.26% | -21.63% | -22.29% | -4.38% |
| Total Common Equity | 110.18% | 110.62% | 113.33% | 113.22% | -165.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 110.18% | 110.62% | 113.33% | 113.22% | -165.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 110.18% | 110.62% | 113.33% | 113.22% | -165.42% |
|
|
|||||